Potential biomarkers of an exaggerated response to endotoxemia

Biomarkers

Volumn 12, Issue 3, 2007, Pages 287-302

  Kasthuri, R S ^a   Wroblewski, M ^a   Jilma, B ^b,c   Key, N S ^d   Nelsestuen, G L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase reactants; Biomarkers; Complement; Human; Lipopolysaccharide

Indexed keywords

AMYLOID A PROTEIN; BIOLOGICAL MARKER; ENDOTOXIN; ESTERASE INHIBITOR; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NORMAL HUMAN; OXIDATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; APOLIPOPROTEIN C-III; BIOLOGICAL MARKERS; BLOOD PROTEINS; BODY TEMPERATURE; C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; COMPLEMENT C1 INHIBITOR PROTEIN; ENDOTOXEMIA; ENDOTOXINS; GLYCOSYLATION; HUMANS; MALE; PROTEOME; SERUM AMYLOID A PROTEIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

BACTERIA (MICROORGANISMS);

EID: 34247589639     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500601160536     Document Type: Article

References (49)

1. Adam, BL, Davis, JW, Ward, MD, Clements, MA, Cazares, LH, Semmes, OJ, Schellhammer, PF, Yasui, Y., Feng, Z. and Wright Jr, GL (2002) Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Research, 62, pp. 3609-3614.
2. Adkins, JN, Varnum, SM, Auberry, KJ, Moore, RJ, Angell, NH, Smith, RD, Springer, DL and Pounds, JG (2002) Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Molecular & Cell Proteomics, 1, pp. 947-955.
3. Alessandro, R., Belluco, C. and Kohn, EC. (2005) Proteomic approaches in colon cancer: Promising tools for new cancer markers and drug target discovery. Clinical Colorectal Cancer, 4, pp. 396-402.
4. Baggerly, KA, Morris, JS and Coombes, KR (2004) Reproducibility of SELDI-TOF protein patterns in serum: Comparing data sets from different experiments. Bioinformatics, 20, pp. 777-785.
5. Baggerly, KA, Morris, JS, Edmonson, SR and Coombes, KR (2005) Signal in noise: Evaluating reported reproducibility of serum proteomic tests for ovarian cancer. Journal of the National Cancer Institute, 97, pp. 307-309.
6. Bondarenko, PV, Cockrill, SL, Watkins, LK, Cruzado, ID and Macfarlane, RD (1999) Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. Journal of Lipid Research, 40, pp. 543-555.
7. Brower, MS and Harpel, PC (1982) Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase. Journal of Biological Chemistry, 257, pp. 9849-9854.
8. Caliezi, C., Wuillemin, WA, Zeerleder, S., Redondo, M., Eisele, B. and Hack, CE (2000) C1-Esterase inhibitor: An anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacological Reviews, 52, pp. 91-112.
9. Check, E. (2004) Proteomics and cancer: Running before we can walk?. Nature, 429, pp. 496-497.
10. Chien, JY, Jerng, JS, Yu, CJ and Yang, PC (2005) Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Critical Care Medicine, 33, pp. 1688-1693.
11. Dayal, B. and Ertel, NH (2002) ProteinChip technology: A new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease. Journal of Proteome Research, 1, pp. 375-380.
12. Deitch, EA (1998) Animal models of sepsis and shock: A review and lessons learned. Shock, 9, pp. 1-11.
13. Derhaschnig, U., Bergmair, D., Marsik, C., Schlifke, I., Wijdenes, J. and Jilma, B. (2004) Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia. Critical Care Medicine, 32, pp. 1136-1140.
14. Derhaschnig, U., Pernerstorfer, T., Knechtelsdorfer, M., Hollenstein, U., Panzer, S. and Jilma, B. (2003) Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia. Critical Care Medicine, 31, pp. 1108-1112.
15. Fink, MP and Heard, SO (1990) Laboratory models of sepsis and septic shock. Journal of Surgical Research, 49, pp. 186-196.
16. Fiuza, C. and Suffredini, AF (2001) Human models of innate immunity: local and systemic inflammatory responses. Journal of Endotoxin Research, 7, pp. 385-388.
17. Gillespie, M. (2003) Affordable proteomics: The two-hybrid systems. Current Opinion in Molecular Therapeutics, 5, pp. 266-270.
18. Grossman, HB, Messing, E., Soloway, M., Tomera, K., Katz, G., Berger, Y. and Shen, Y. (2005) Detection of bladder cancer using a point-of-care proteomic assay. Journal of the American Medical Association, 293, pp. 810-816.
19. Hansel, A., Heinemann, SH and Hoshi, T. (2005) Heterogeneity and function of mammalian MSRs: Enzymes for repair, protection and regulation. Biochimica et Biophysica Acta, 1703, pp. 239-247.
20. Hari-Dass, R., Shah, C., Meyer, DJ and Raynes, JG (2005) Serum amyloid A protein binds to outer membrane protein A of gram-negative bacteria. Journal of Biological Chemistry, 280, pp. 18562-18567.
21. Hollenstein, U., Homoncik, M., Knobl, P., Pernerstorfer, T., Graggaber, J., Eichler, HG, Handler, S. and Jilma, B. (2002) Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans. Clinical Pharmacology & Therapeutics, 71, pp. 368-374.
22. Jacquemier, J., Ginestier, C., Rougemont, J., Bardou, VJ, Charafe-Jauffret, E., Geneix, J., Adelaide, J., Koki, A., Houvenaeghel, G., Hassoun, J., Maraninchi, D., Viens, P., Birnbaum, D. and Bertucci, F. (2005) Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Research, 65, pp. 767-779.
23. Jilma, B., Marsik, C., Kovar, F., Wagner, OF, Jilma-Stohlawetz, P. and Endler, G. (2005) The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia. Blood, 105, pp. 2380-2383.
24. Jilma, B., Marsik, C., Mayr, F., Graninger, MT, Taylor Jr, FB, Ribel, MC, Erhardtsen, E., Handler, S. and Eichler, HG (2002) Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans. Clinical Pharmacology & Therapeutics, 72, pp. 403-410.
25. Kiernan, UA, Tubbs, KA, Nedelkov, D., Niederkofler, EE and Nelson, RW (2003) Detection of novel truncated forms of human serum amyloid A protein in human plasma. FEBS Letters, 537, pp. 166-170.
26. Bihan, T Le, Duewel, HS and Figeys, D. (2003) On-line strong cation exchange micro-HPLC-ESI-MS/MS for protein identification and process optimization. Journal of the American Society for Mass Spectrometry, 14, pp. 719-727.
27. Liao, H., Kuhn, E., Chin, W., Chang, B., Jones, MD, O'Neil, S., Clauser, KR, Karl, J., Hasler, F., Roubenoff, R., Zolg, W. and Guild, BC (2004) Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis & Rheumatism, 50, pp. 3792-3803.
28. Moore, F. (2004) Complement, ASM Press, Washington, DC
29. Nelsestuen, GL, Martinez, MB, Hertz, MI, Savik, K. and Wendt, CH (2005) Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics, 5, pp. 1705-1713.
30. Nelsestuen, GL, Zhang, Y., Martinez, MB, Key, NS, Jilma, B., Verneris, M., Sinaiko, A. and Kasthuri, RS (2005) Plasma protein profiling: Unique and stable features of individuals. Proteomics, 5, pp. 4012-4024.
31. Nuijens, JH, Eerenberg-Belmer, AJ, Huijbregts, CC, Schreuder, WO, Felt-Bersma, RJ, Abbink, JJ, Thijs, LG and Hack, CE (1989) Proteolytic inactivation of plasma C1-inhibitor in sepsis. Journal of Clinical Investigation, 84, pp. 443-450.
32. Pajkrt, D., Doran, JE, Koster, F., Lerch, PG, Arnet, B., van der Poll, T., Cate, JW ten and van Deventer, SJ (1996) Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. Journal of Experimental Medicine, 184, pp. 1601-1608.
33. Pajkrt, D., Lerch, PG, van der Poll, T., Levi, M., Illi, M., Doran, JE, Aenet, B., Ende, A van den, Cate, JW ten and van Deventer, SJ (1997) Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia. Thrombosis & Haemostasis, 77, pp. 303-307.
34. Petricoin, EF, Ardekani, AM, Hitt, BA, Levine, PJ, Fusaro, VA, Steinberg, SM, Mills, GB, Simone, C., Fishman, DA, Kohn, EC and Loitta, LA (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359, pp. 572-577.
35. Petricoin, EF III, Ornstein, DK and Paweletz, CP (2002) Serum proteomic patterns for detection of prostate cancer. Journal of the National Cancer Institute, 94, pp. 1576-1578.
36. Pieper, R., Gatlin, CL, Makusky, AJ, Ardekani, A., Hackett, PS, Hitt, BA, Velassco, A., Trucco, C., Wiegand, L., Wood, K., Simone, CB, Levine, PJ, Linehan, WM, Emmert-Buck, MR, Steinberg, SM, Kohn, EC and Liotta, LA (2003) The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics, 3, pp. 1345-1364.
37. Pleiner, J., Schaller, G., Mittermayer, F., Zorn, S., Marsik, C., Polterauer, S., Kapiotis, S. and Wolzt, M. (2004) Simvastatin prevents vascular hyporeactivity during inflammation. Circulation, 110, pp. 3349-3354.
38. Poon, TC, Hui, AY, Chan, HL, Ang, IL, Chow, SM, Wong, N. and Sung, JJ (2005) Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: A pilot study. Clinical Chemistry, 51, pp. 328-335.
39. Schroder, NW and Schumann, RR (2005) Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infectious Diseases, 5, pp. 156-164.
40. Schultz, MJ and van der Poll, T. (2002) Animal and human models for sepsis. Annals of Medicine, 34, pp. 573-581.
41. Stein, PE and Carrell, RW (1995) What do dysfunctional serpins tell us about molecular mobility and disease?. Nature Structural Biology, 2, pp. 96-113.
42. Suffredini, AF, Fantuzzi, G., Badolato, R., Oppenheim, JJ and O'Grady, NP (1999) New insights into the biology of the acute phase response. Journal of Clinical Immunology, 19, pp. 203-214.
43. Uhlar, CM and Whitehead, AS. (1999) Serum amyloid A, the major vertebrate acute-phase reactant. European Journal of Biochemistry, 265, pp. 501-523.
44. van Deventer, SJ, Buller, HR, Cate, JW ten, Aarden, LA, Hack, CE and Sturk, A. (1990) Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood, 76, pp. 2520-2526.
45. Villar, J., Maca-Meyer, N., Perez-Mendez, L. and Flores, C. (2004) Bench-to-bedside review: Understanding genetic predisposition to sepsis. Critical Care, 8, pp. 180-189.
46. Walport, MJ (2001) Complement. Part I. New England Journal of Medicine, 344, pp. 1058-1066.
47. Walport, MJ (2001) Complement. Part II. New England Journal of Medicine, 344, pp. 1140-1144.
48. Wichterman, KA, Baue, AE and Chaudry, IH (1980) Sepsis and septic shock - a review of laboratory models and a proposal. Journal of Surgical Research, 29, pp. 189-201.
49. Wurfel, MM, Park, WY and Radella, F. (2005) Identification of high and low responders to lipopolysaccharide in normal subjects: An unbiased approach to identify modulators of innate immunity. Journal of Immunology, 175, pp. 2570-2578.